These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 37728381)

  • 1. Genomic analysis of spinal meningiomas: correlation with histopathological grade.
    Driver J; Santagata S; Bi WL; Chi JH
    J Neurosurg Spine; 2023 Dec; 39(6):729-733. PubMed ID: 37728381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas.
    Arslantas A; Artan S; Oner U; Durmaz R; Müslümanoğlu H; Atasoy MA; Başaran N; Tel E
    Acta Neurol Belg; 2002 Jun; 102(2):53-62. PubMed ID: 12161900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
    Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
    Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of NF2 alteration in grade I meningiomas revisited; prognostic impact integrated with extent of resection, tumour location, and Ki-67 index.
    Teranishi Y; Okano A; Miyawaki S; Ohara K; Ishigami D; Hongo H; Dofuku S; Takami H; Mitsui J; Ikemura M; Komura D; Katoh H; Ushiku T; Ishikawa S; Shin M; Nakatomi H; Saito N
    Acta Neuropathol Commun; 2022 May; 10(1):76. PubMed ID: 35570314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
    Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
    Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecularly integrated grade for meningioma.
    Driver J; Hoffman SE; Tavakol S; Woodward E; Maury EA; Bhave V; Greenwald NF; Nassiri F; Aldape K; Zadeh G; Choudhury A; Vasudevan HN; Magill ST; Raleigh DR; Abedalthagafi M; Aizer AA; Alexander BM; Ligon KL; Reardon DA; Wen PY; Al-Mefty O; Ligon AH; Dubuc AM; Beroukhim R; Claus EB; Dunn IF; Santagata S; Bi WL
    Neuro Oncol; 2022 May; 24(5):796-808. PubMed ID: 34508644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of aggressive behavior.
    Kumar S; Kakkar A; Suri V; Kumar A; Bhagat U; Sharma MC; Singh M; Suri A; Sarkar C
    Neurol India; 2014; 62(4):376-82. PubMed ID: 25237942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biological determinations of meningioma progression and recurrence.
    Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
    PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular landscapes of longitudinal NF2/22q and non-NF2/22q meningiomas show different life histories.
    Ng HK; Li KK; Chung NY; Chan JY; Poon MF; Wong QH; Kwan JS; Poon WS; Chen H; Chan DT; Shi ZF; Mao Y
    Brain Pathol; 2023 May; 33(3):e13120. PubMed ID: 36167400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infarction with associated pseudosarcomatous changes mimics anaplasia in otherwise grade I meningiomas.
    Bale TA; Benhamida J; Roychoudury S; Villafania L; Wrzolek MA; Bouffard JP; Bapat K; Ladanyi M; Rosenblum MK
    Mod Pathol; 2020 Jul; 33(7):1298-1306. PubMed ID: 32047229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences.
    Och W; Szmuda T; Kulbacki K; Witek K; Sikorska B; Zakrzewska M; Springer J; Reszeć J; Parda A; Liberski PP
    Neurol Neurochir Pol; 2016; 50(6):395-402. PubMed ID: 27480481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings.
    Al-Mefty O; Kadri PA; Pravdenkova S; Sawyer JR; Stangeby C; Husain M
    J Neurosurg; 2004 Aug; 101(2):210-8. PubMed ID: 15309910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological classification and molecular genetics of meningiomas.
    Mawrin C; Perry A
    J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The molecular genetics of meningiomas and genotypic/phenotypic correlations].
    Dezamis E; Sanson M
    Rev Neurol (Paris); 2003 Sep; 159(8-9):727-38. PubMed ID: 13679715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.
    Roehrkasse AM; Peterson JEG; Fung KM; Pelargos PE; Dunn IF
    Front Oncol; 2022; 12():846232. PubMed ID: 35299730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-grade meningiomas: biology and implications.
    Bi WL; Prabhu VC; Dunn IF
    Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications.
    Cai DX; Banerjee R; Scheithauer BW; Lohse CM; Kleinschmidt-Demasters BK; Perry A
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):628-36. PubMed ID: 11398839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology and genetics of meningiomas.
    Alahmadi H; Croul SE
    Semin Diagn Pathol; 2011 Nov; 28(4):314-24. PubMed ID: 22195409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses at 1p, 9q, 10q, 14q, and 22q in the progression of aggressive meningiomas and undifferentiated meningeal sarcomas.
    Lamszus K; Kluwe L; Matschke J; Meissner H; Laas R; Westphal M
    Cancer Genet Cytogenet; 1999 Apr; 110(2):103-10. PubMed ID: 10214357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.